Request Demo
Last update 08 May 2025
Shanghai Jiaolian Drug Development Co. Ltd.
Subsidiary Company|2012|Shanghai Shi, China
Subsidiary Company|2012|Shanghai Shi, China
Last update 08 May 2025
Overview
Tags
Other Diseases
Neoplasms
Skin and Musculoskeletal Diseases
Monoclonal antibody
Antibody drug conjugate (ADC)
Bispecific antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT06470191
A Multicenter, Randomized, Controlled, Open Phase II/III Clinical Study to Evaluate the Efficacy and Safety of B007 Versus Cyclosporine in the Treatment of Primary Membranous Nephropathy.
NCT06413654
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Study to Evaluate the Efficacy and Safety of B001 Injection in Aquaporin-4 Antibody Positive Patients With Neuromyelitis Optica Spectrum Disorder
CTR20242028
一项评价重组抗CD20人源化单克隆抗体皮下注射液对比环孢素治疗原发性膜性肾病的有效性和安全性的多中心、随机、对照、开放的Ⅱ/Ⅲ期临床研究
[Translation] A multicenter, randomized, controlled, open-label phase II/III clinical study to evaluate the efficacy and safety of subcutaneous injection of recombinant anti-CD20 humanized monoclonal antibody versus cyclosporine in the treatment of primary membranous nephropathy
100 Clinical Results associated with Shanghai Jiaolian Drug Development Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Jiaolian Drug Development Co. Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Jiaolian Drug Development Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 15 May 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
2
Preclinical
Phase 1 Clinical
2
1
Phase 2 Clinical
Phase 3 Clinical
2
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free